PET/SPECT imaging agents for neurodegenerative diseases. - Wikidata - wikimedia - TriplyDB

PET/SPECT imaging agents for neurodegenerative diseases.

PET/SPECT imaging agents for neurodegenerative diseases.

http://www.wikidata.org/entity/Q34156602

about

PET neuroimaging studies of [(18)F]CABS13 in a double transgenic mouse model of Alzheimer's disease and nonhuman primates Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer׳s disease Brain imaging and networks in restless legs syndrome.Difluorocarbene-Derived Trifluoromethylthiolation and [(18)F]Trifluoromethylthiolation of Aliphatic Electrophiles Compounds for imaging amyloid-β deposits in an Alzheimer's brain: a patent review.Advances in Neuroimaging for Neurodegenerative Disease.Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT.Metal complexes for multimodal imaging of misfolded protein-related diseases.Neutral merocyanine dyes: for in vivo NIR fluorescence imaging of amyloid-β plaques.Fluorodopa is a Promising Fluorine-19 MRI Probe for Evaluating Striatal Dopaminergic Function in a Rat Model of Parkinson's Disease.In vivo near-infrared and Cerenkov luminescence imaging of amyloid-β deposits in the brain: a fluorinated small molecule used for dual-modality imaging.

P2860

Q28833503-952246C2-8EAA-4AED-AFCE-F54ED147189B Q31025427-454F2B82-D8E2-4BD5-9F75-B1390ED66246 Q31142064-B9968E33-1D5F-47CD-B748-1C2BFCFB7DA9 Q36407430-A9C9B177-055B-4D23-9278-6312A3DB76EE Q38369228-ECDC1468-E9D5-46D4-96AF-4AAD883E1652 Q38663083-56703609-7735-4F58-BACE-D8EDD305C173 Q42315307-9DCCDBF6-977C-45FF-94AD-DF94EDFA4E50 Q47737459-F9BBC4CF-059C-4362-B7BA-CD1F151012D4 Q47769966-40B27494-57F1-4830-BA42-1EAE161167D3 Q48452595-812CFE5A-D89F-41D1-A770-72BE3B6203F2 Q48472069-7F259E6B-6C7D-4B85-8906-F9F29903E1A0

P2860

PET/SPECT imaging agents for neurodegenerative diseases.

http://www.wikidata.org/entity/Q34156602

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

PET/SPECT imaging agents for neurodegenerative diseases.

@ast

PET/SPECT imaging agents for neurodegenerative diseases.

@en

PET/SPECT imaging agents for neurodegenerative diseases.

@nl

type

label

PET/SPECT imaging agents for neurodegenerative diseases.

@ast

PET/SPECT imaging agents for neurodegenerative diseases.

@en

PET/SPECT imaging agents for neurodegenerative diseases.

@nl

prefLabel

PET/SPECT imaging agents for neurodegenerative diseases.

@ast

PET/SPECT imaging agents for neurodegenerative diseases.

@en

PET/SPECT imaging agents for neurodegenerative diseases.

@nl

P1433

Q34156602-5BBE5B9D-FFD1-406D-BCF1-B3415A24F59F

P1476

Q34156602-744B1554-9B40-434A-9768-4A67E4F2A4D2

P2093

Q34156602-3009F23E-D52C-48E7-988B-9CFE59B59F40

Q34156602-3874B8FE-0607-4B59-A3E7-8BCF5EB7D079

Q34156602-F669F023-F498-4755-BBE4-472AB1ED2F08

P2860

Q34156602-05D4434D-C4F0-45D2-9B85-836948F54852

Q34156602-0E297B90-CD13-448F-80D4-88B7BE7E00A9

Q34156602-1A441AB5-2F8D-42A7-8E06-62D0348107EE

Q34156602-255552B0-E9DE-4D03-9CF5-4C8D76442513

Q34156602-26E674A9-B99D-4D04-A6ED-0EA68A8B9D09

Q34156602-33304A1D-0B02-4510-A546-65796B5B5EF9

Q34156602-360A8A7F-E283-4006-8540-A6C756CD3A15

Q34156602-37CC136B-4CBF-47F8-BFB6-9BBD2628D36C

Q34156602-3C3B2F38-C6D0-4BFF-B60D-4187F035FFB2

Q34156602-3EA56A23-E924-48AF-90C2-38232A6A0DEE

P304

Q34156602-AB2E976D-11AC-4CB0-8B32-852BE0D0A192

P31

Q34156602-9E946E74-3DDB-489F-A141-9D0261E7BB96

P356

Q34156602-CF5A2E19-05EE-4563-8668-91F14BEF5A68

P433

Q34156602-D70F50F7-B5CD-4BF4-80EA-913C3E626F0B

P478

Q34156602-55376DEA-6D4C-4A9B-B19F-E1F7469D42AA

P577

Q34156602-EBF2F24E-382C-4B6E-BF90-D667E309C774

P698

Q34156602-05C679F2-B2E4-4ECE-9DC7-E49E5BB78C78

P921

Q34156602-C682A174-D79E-4826-AFBE-EA80A4158663

P932

Q34156602-25F05B82-925B-4A04-AB41-82619DA763D9

P356

P1433

Chemical Society Reviews

P1476

PET/SPECT imaging agents for neurodegenerative diseases.

@en

P2093

Hank F Kung

http://www.w3.org/2001/XMLSchema#string

Karl Ploessl

http://www.w3.org/2001/XMLSchema#string

Lin Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's Disease

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Development of positron emission tomography β-amyloid plaque imaging agents

In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133

A benzo[a]quinolizine derivative with a neuroleptic-like action on cerebral monoamine turnover

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective.

Imaging biomarkers in Parkinson's disease.

In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.

P304

6683-6691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C3CS60430F

http://www.w3.org/2001/XMLSchema#string

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24676152

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

4159420

http://www.w3.org/2001/XMLSchema#string